![Manolo Bellotto](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Manolo Bellotto
Corporate Officer/Principal bei GAIN THERAPEUTICS, INC.
Aktive Positionen von Manolo Bellotto
Unternehmen | Position | Beginn | Ende |
---|---|---|---|
GAIN THERAPEUTICS, INC. | Corporate Officer/Principal | 20.09.2022 | - |
Präsident | 01.01.2018 | 20.09.2022 | |
GT Gain Therapeutics SA
![]() GT Gain Therapeutics SA Pharmaceuticals: MajorHealth Technology GT Gain Therapeutics SA operates as a preclinical stage biotech firm developing a class of next generation brain-penetrant non-competitive pharmacological chaperones for the treatment of devastating diseases using the proprietary SEE-Tx technology. Its projects include Beta-galactosidase GLB1 gene and Glucosylceramidase GBA gene. The company was founded by Lorenzo Leoni and is headquartered in Lugano, Switzerland. | Corporate Officer/Principal | - | - |
Präsident | 01.01.2018 | - | |
Mederis | Corporate Officer/Principal | 01.03.2013 | - |
Karriereverlauf von Manolo Bellotto
Ehemalige bekannte Positionen von Manolo Bellotto
Unternehmen | Position | Beginn | Ende |
---|---|---|---|
Aptitude Health LLC
![]() Aptitude Health LLC Medical/Nursing ServicesHealth Services Aptitude Health LLC is a healthcare company based in Atlanta, GA. The company is the market leader in evidence-based solutions for life science companies seeking to identify, develop, and commercialize oncology and hematology innovations. The company's team of experts has a proven track record of success and is backed by unparalleled access to disease-state experts and healthcare professionals. Aptitude Health is dedicated to transforming the world's growing scientific and clinical knowledge into better cancer patient outcomes. The company was founded by Alexei Rojanets, who has been the CEO since incorporation. | Corporate Officer/Principal | 01.01.2009 | 01.01.2013 |
European Society for Medical Oncology
![]() European Society for Medical Oncology Medical/Nursing ServicesHealth Services The European Society for Medical Oncology (ESMO) is a leading medical oncology society that provides a professional network for its members and works with national societies across Europe. The non-profit company is based in Lugano, Switzerland. ESMO's position on a wide range of legislative and non-legislative policy files on both EU and levels is available to learn about. Raffaella Casolino is the third ESMO young medical oncologist serving as a cancer expert on the WHO Cancer Control team. ESMO's Young Oncologists Corner is dedicated to providing educational and networking opportunities for medical oncologists under 40. | Vertrieb & Marketing | 01.06.2008 | 01.01.2009 |
DKSH HOLDING AG | Vertrieb & Marketing | 01.01.2007 | 01.05.2008 |
Helsinn Healthcare SA
![]() Helsinn Healthcare SA Pharmaceuticals: MajorHealth Technology Helsinn Healthcare SA develops and provides licenses for drugs. The firm offers services to oncology, cancer supportive care, pain and inflammation, gastrointestinal fields. The company was founded by Gabriele Braglia in 1976 and is headquartered in Pazzallo, Switzerland. | Vertrieb & Marketing | 01.01.2004 | 01.12.2006 |
Chemo SA
![]() Chemo SA Pharmaceuticals: MajorHealth Technology Chemo SA is an Argentinean company that produces pharmaceuticals. | Vertrieb & Marketing | 01.01.2003 | 01.04.2004 |
Ausbildung von Manolo Bellotto
University of Zurich | Doctorate Degree |
Statistik
International
Schweiz | 7 |
Vereinigte Staaten | 3 |
Argentinien | 2 |
Operativ
Corporate Officer/Principal | 4 |
Sales & Marketing | 4 |
President | 2 |
Sektoral
Health Technology | 5 |
Health Services | 3 |
Distribution Services | 2 |
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
Börsennotierte Unternehmen | 2 |
---|---|
GAIN THERAPEUTICS, INC. | Health Technology |
DKSH HOLDING AG | Distribution Services |
Private Unternehmen | 6 |
---|---|
GT Gain Therapeutics SA
![]() GT Gain Therapeutics SA Pharmaceuticals: MajorHealth Technology GT Gain Therapeutics SA operates as a preclinical stage biotech firm developing a class of next generation brain-penetrant non-competitive pharmacological chaperones for the treatment of devastating diseases using the proprietary SEE-Tx technology. Its projects include Beta-galactosidase GLB1 gene and Glucosylceramidase GBA gene. The company was founded by Lorenzo Leoni and is headquartered in Lugano, Switzerland. | Health Technology |
Mederis | |
Helsinn Healthcare SA
![]() Helsinn Healthcare SA Pharmaceuticals: MajorHealth Technology Helsinn Healthcare SA develops and provides licenses for drugs. The firm offers services to oncology, cancer supportive care, pain and inflammation, gastrointestinal fields. The company was founded by Gabriele Braglia in 1976 and is headquartered in Pazzallo, Switzerland. | Health Technology |
European Society for Medical Oncology
![]() European Society for Medical Oncology Medical/Nursing ServicesHealth Services The European Society for Medical Oncology (ESMO) is a leading medical oncology society that provides a professional network for its members and works with national societies across Europe. The non-profit company is based in Lugano, Switzerland. ESMO's position on a wide range of legislative and non-legislative policy files on both EU and levels is available to learn about. Raffaella Casolino is the third ESMO young medical oncologist serving as a cancer expert on the WHO Cancer Control team. ESMO's Young Oncologists Corner is dedicated to providing educational and networking opportunities for medical oncologists under 40. | Health Services |
Chemo SA
![]() Chemo SA Pharmaceuticals: MajorHealth Technology Chemo SA is an Argentinean company that produces pharmaceuticals. | Health Technology |
Aptitude Health LLC
![]() Aptitude Health LLC Medical/Nursing ServicesHealth Services Aptitude Health LLC is a healthcare company based in Atlanta, GA. The company is the market leader in evidence-based solutions for life science companies seeking to identify, develop, and commercialize oncology and hematology innovations. The company's team of experts has a proven track record of success and is backed by unparalleled access to disease-state experts and healthcare professionals. Aptitude Health is dedicated to transforming the world's growing scientific and clinical knowledge into better cancer patient outcomes. The company was founded by Alexei Rojanets, who has been the CEO since incorporation. | Health Services |
- Börse
- Insiders
- Manolo Bellotto
- Erfahrung